Millennium Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,255
| Closed | -$38K | – | 8162 |
|
|
2021
Q4 | $38K | Sell |
12,255
-54,844
| -82% | -$185K | ﹤0.01% | 6535 |
|
|
2021
Q3 | $242K | Buy |
67,099
+15,104
| +29% | +$57K | ﹤0.01% | 5983 |
|
|
2021
Q2 | $186K | Buy |
51,995
+28,177
| +118% | +$99.4K | ﹤0.01% | 6051 |
|
|
2021
Q1 | $93K | Sell |
23,818
-274,956
| -92% | -$1.14M | ﹤0.01% | 5704 |
|
|
2020
Q4 | $1.25M | Buy |
+298,774
| New | +$1.15M | ﹤0.01% | 3580 |
|
|
2020
Q2 | – | Sell |
-53,661
| Closed | -$203K | – | 4888 |
|
|
2020
Q1 | $203K | Sell |
53,661
-381,398
| -88% | -$1.87M | ﹤0.01% | 3389 |
|
|
2019
Q4 | $2.75M | Buy |
435,059
+393,351
| +943% | +$2.31M | ﹤0.01% | 2401 |
|
|
2019
Q3 | $175K | Sell |
41,708
-443,387
| -91% | -$1.89M | ﹤0.01% | 3827 |
|
|
2019
Q2 | $2.26M | Sell |
485,095
-1,328,500
| -73% | -$6.18M | ﹤0.01% | 2334 |
|
|
2019
Q1 | $9.61M | Buy |
1,813,595
+832,173
| +85% | +$3.8M | 0.01% | 1289 |
|
|
2018
Q4 | $3.63M | Buy |
981,422
+859,292
| +704% | +$3.02M | 0.01% | 1804 |
|
|
2018
Q3 | $342K | Sell |
122,130
-27,341
| -18% | -$76.7K | ﹤0.01% | 3422 |
|
|
2018
Q2 | $441K | Buy |
149,471
+35,237
| +31% | +$83.6K | ﹤0.01% | 3221 |
|
|
2018
Q1 | $257K | Buy |
114,234
+9,274
| +9% | +$21.7K | ﹤0.01% | 3275 |
|
|
2017
Q4 | $310K | Buy |
+104,960
| New | +$290K | ﹤0.01% | 3332 |
|
|
2017
Q2 | – | Sell |
-18,891
| Closed | -$36K | – | 4206 |
|
|
2017
Q1 | $36K | Buy |
+18,891
| New | +$36.4K | ﹤0.01% | 3412 |
|
|
2016
Q4 | – | Sell |
-888,556
| Closed | -$2.4M | – | 4045 |
|
|
2016
Q3 | $2.4M | Sell |
888,556
-668,563
| -43% | -$1.7M | ﹤0.01% | 1842 |
|
|
2016
Q2 | $3.67M | Buy |
1,557,119
+350,316
| +29% | +$967K | 0.01% | 1447 |
|
|
2016
Q1 | $3.9M | Buy |
1,206,803
+1,036,497
| +609% | +$3.83M | 0.01% | 1392 |
|
|
2015
Q4 | $816K | Buy |
170,306
+152,434
| +853% | +$864K | ﹤0.01% | 2402 |
|
|
2015
Q3 | $99K | Sell |
17,872
-1,553,328
| -99% | -$11.5M | ﹤0.01% | 3274 |
|
|
2015
Q2 | $12.5M | Sell |
1,571,200
-291,392
| -16% | -$2.5M | 0.02% | 847 |
|
|
2015
Q1 | $19.6M | Buy |
1,862,592
+1,583,971
| +569% | +$21.6M | 0.04% | 674 |
|
|
2014
Q4 | $3.35M | Sell |
278,621
-379,267
| -58% | -$5.76M | 0.01% | 1631 |
|
|
2014
Q3 | $11.2M | Buy |
657,888
+235,285
| +56% | +$3.41M | 0.03% | 807 |
|
|
2014
Q2 | $5.1M | Buy |
422,603
+262,564
| +164% | +$2.49M | 0.01% | 1208 |
|
|
2014
Q1 | $1.35M | Sell |
160,039
-201,504
| -56% | -$1.63M | ﹤0.01% | 2050 |
|
|
2013
Q4 | $2.13M | Buy |
361,543
+331,566
| +1,106% | +$1.71M | 0.01% | 1788 |
|
|
2013
Q3 | $163K | Buy |
+29,977
| New | +$144K | ﹤0.01% | 3143 |
|
Other funds holding BDSI
Millennium Management's BDSI Position: Q1 2022 in Review
Millennium Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 12,255 shares — an estimated $38K sold.
Millennium Management first reported a position in BDSI in Q3 2013 and held it in 29 quarters. The position peaked at $19.6M in Q1 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Millennium Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Millennium Management sold 12,255 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $38K.
- Millennium Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 29 quarters.
- Millennium Management's BioDelivery Sciences International, Inc. position peaked at $19.6M in Q1 2015.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.